MIAMI, FL (October 26, 2022) – The 25th BioFlorida Annual Conference will unite the most prominent leaders of the Florida life sciences community from November 2-4 at the Hyatt Regency Miami. The Conference provides an opportunity for the life sciences community to highlight the latest in science, business, and public policy, showcase Florida’s successes, and collaborate to fuel future growth. WHO: BioFlorida is the voice of Florida’s life sciences ecosystem representing 6,700 establishments and research organizations in BioPharma, MedTech, HealthIT, and Health Systems that employ nearly 94,000 Floridians. Attendees include executives, entrepreneurs, industry professionals, scientists, researchers, universities, health systems, hospitals, investors, federal and state policymakers, economic development agencies, and service providers from the state’s life sciences industry. Chris Sprowls, Speaker of the Florida House of Representatives, will join to provide a welcome and help kick off the industry celebrations of 25 years of innovation. The keynote speaker at the Conference is Fred Hassan, a Director with the private equity firm, Warburg Pincus, and board member of Precigen, IntegraConnect, Prometheus Biosciences, and BridgeBio. The industry titan will draw on his years of success leading companies like Schering-Plough Corporation, where he served as Chairman and CEO from 2003 until its merger with Merck & Co. in 2009, and Pharmacia Corporation, where we served as Chairman and CEO from 2001 to 2003 until its acquisition by Pfizer Inc., and discuss strategies for success in today’s environment during his keynote, Reinvent: A Leaders Playbook. Jeffrey Duerk, PhD, Executive Vice President for Academic Affairs and Provost for the University of Miami, will also provide a keynote on Connecting Academics, Research, and Industry in Florida and on the Global Stage. WHAT: The BioFlorida Annual Conference will foster collaboration, build upon the value and growth of the life sciences industry, and explore state policy solutions with general sessions on Cancer Care Advances from the Perspective of the Physician and Patient; Fueling Florida’s Growth: Positioning Florida to Attract Talent and Companies from across the Country and World; CEO Panel: Learn from the Experts; CEO Panel: Learn from the Experts; and Healthcare in Florida – Fireside Chat with State Legislators with Sen. Ana Maria Rodriguez and Rep. Tom Fabricio. CEO, Research, and Incubator Forums will bring together professionals from around the state to share best practices and build partnerships. Attendees will be immersed in three unique interactive programming paths: BioScience, BioTrends, and BioBusiness. - BioScience sessions will feature Florida-based companies, researchers, top experts, and lawmakers, like Congresswoman Debbie Wasserman Schultz, to discuss emerging therapies and research in cancer care, rare disease, neurology and movement disorders, and gene and cell therapy.
- BioTrends sessions will showcase industry innovation and identify current trends in manufacturing, digital health, and machine learning, and explore how we can learn from the Pandemic in the fight against infectious diseases.
- BioBusiness will spotlight this year’s most innovative companies that have experienced significant growth and met major milestones; discuss how MedTech is leveraged to improve the patient, physician, and clinical experience; and share keys to achieve commercialization success. A panel of investors will also discuss funding strategies for the year ahead.
Seed and early-stage life science companies will compete during BioPitch, providing a platform for some of Florida’s most innovative companies to pitch to 25+ life science investors in closed-door sessions. Finalists will present during the General Session, and the winner will receive $10,000. BioFlorida received a record number of 55 BioPitch applicants this year. BioPitch semifinalists include: 3Daughters; Ambulero, Inc.; Andante Biologics; Arcomedlab; CirculaTech LLC.; DermaSensor Inc.; DigiBeat Health Monitoring Systems; FoxSeq LLC; i-Function, Inc.; InnoCare Urologics LLC; Lumaegis, Inc; NeXtGen Biologics; Olatec Therapeutics, LLC; TAS Medical, Inc.; Trace Orthopedics; and VuEssence. The BioFlorida Annual Conference recognizes individuals and organizations throughout unique categories for their outstanding achievements, including Researcher of the Year, Deal of the Year, Entrepreneur of the Year, Company of the Year, Leadership Award, and Lifetime Achievement. To view the full agenda or to register, visit https://www.bioflorida.com/page/2022Agenda. To receive your media credentials for this event, please email Courtney Cox at CourtneyC@TheMooreAgency.com. # # # About BioFlorida BioFlorida is the voice of Florida’s life sciences industry, representing 6,700 establishments and research organizations in BioPharma, MedTech, Digital Health, and Health Systems that collectively employ nearly 94,00 Floridians (Source: TEConomy/BIO). BioFlorida’s member driven initiatives provide a strong business climate for the advancement of innovative products and technology that improve lives and promote economic benefits to the state. |
